Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 4, 2025 • 7:00 AM ET

Date/Time Source News Release
01/03/2025 07:00 AM EST GlobeNewswire CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue
12/23/2024 07:00 AM EST GlobeNewswire CytoSorbents Rights Offering Begins
12/12/2024 07:00 AM EST GlobeNewswire CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
12/09/2024 07:00 AM EST GlobeNewswire CytoSorbents Announces Rights Offering
11/26/2024 07:00 AM EST GlobeNewswire CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference
11/11/2024 07:30 AM EST GlobeNewswire CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India
11/07/2024 04:05 PM EST GlobeNewswire CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
11/04/2024 07:00 AM EST GlobeNewswire CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
10/22/2024 07:00 AM EDT GlobeNewswire FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review
10/17/2024 07:00 AM EDT GlobeNewswire CytoSorbents to Report Third Quarter 2024 Operating and Financial Results
Page

Additional News

As of January 4, 2025 • 7:00 AM ET

Date/Time Source News Release
01/03/2025 07:28 AM EST SeekingAlpha CytoSorbents sees Q4 product revenue growth of 22%-25% Y/Y
11/14/2024 04:40 AM EST US Earnings Reports Expected earnings - CytoSorbents Corporation
11/11/2024 09:40 AM EST Baystreet CytoSorbents Hops on Alliance with Converge
11/09/2024 01:20 PM EST SeekingAlpha Cytosorbents Corporation (CTSO) Q3 2024 Earnings Call Transcript
11/07/2024 05:25 PM EST SeekingAlpha Cytosorbents GAAP EPS of -$0.08 misses by $0.02, revenue of $9.39M misses by $0.79M
10/22/2024 08:52 AM EDT SeekingAlpha CytoSorbents rises as FDA accepts application for device to reduce bleeding risk in bypass surgery
10/01/2024 07:35 AM EDT SeekingAlpha CytoSorbents spikes on FDA submission for DrugSorb-ATR
08/17/2024 04:41 PM EDT SeekingAlpha Executive reshuffles: The ODP, GrafTech International and ICON Companies in focus
08/13/2024 10:31 PM EDT SeekingAlpha Cytosorbents Corporation (CTSO) Q2 2024 Earnings Call Transcript
08/13/2024 04:35 PM EDT SeekingAlpha Cytosorbents GAAP EPS of -$0.08 beats by $0.02, revenue of $9.9M beats by $0.22M
Page